IGHE and head and neck neoplasm: Furthermore, patients with cancer may develop antitumour IgE: greater numbers of IgE-expressing cells have been observed in head and neck tumours compared to normal mucosa [6] and an IgE derived from pancreatic cancer patients showed antitumoural activity in vitro [7].